Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Cancer

A list of these Cancer articles makes it easy for you to quickly access relevant information. We have prepared the following professional Cancer, hoping to help solve your questions and better understand the product information you care about.
  • New Approval of Olaparib Indication

    New Approval of Olaparib Indication

    2025-03-10

    New Approval of Olaparib IndicationOn January 2nd, AstraZeneca and Merck jointly announced that their PARP inhibitor Lynparza® (Generic name: olaparib) has received approval for a new indication in China. Read More
  • Targeting CDK4/6 in Cancer Drug Development: Challenges and Opportunities

    Targeting CDK4/6 in Cancer Drug Development: Challenges and Opportunities

    2023-09-14

    The cell cycle is tightly regulated to ensure proper cell division and growth. Cyclin-dependent kinases (CDKs) play a crucial role in controlling cell cycle progression. In particular, CDK4 and CDK6 partner with D-type cyclins during the G1 phase to phosphorylate and inactivate the retinoblastoma (R Read More